Evidence map›Paper›PMID 41373747›Full record

ArticleInternational journal of molecular sciences2025

Ana E Garduño-Torres, Manuel G Salgado-Cantú, Silvia Guzmán-Beltrán, Jesús Montoya-Ramírez, Juan Antonio Suárez-Cuenca, Enrique Ortega, David Ricardo Orozco-Solís, Daniela I Uribe-López, María Teresa Herrera, Luis Horacio Gutiérrez-González and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Antigen 85B ofVaccines · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana E Garduño-TorresDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0009-0000-3230-8649
Manuel G Salgado-CantúDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0009-0009-4241-9276
Silvia Guzmán-BeltránDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-7491-1910
Jesús Montoya-RamírezBariatric Surgery Clinic, Centro Médico Nacional "20 de Noviembre", Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City 03104, Mexico.
Juan Antonio Suárez-CuencaLaboratory of Experimental Metabolism and Clinical Research, Department of Clinical Research, Centro Médico Nacional "20 de Noviembre", Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City 03104, Mexico.ORCID 0000-0002-2098-5658
Enrique OrtegaDepartment of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-1480-7740
David Ricardo Orozco-SolísLaboratorio de Cronobiología, Metabolismo y Envejecimiento, Instituto Nacional de Medicina Genómica, Centro de Investigación sobre el Envejecimiento-Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 14330, Mexico.ORCID 0000-0003-1494-7281
Daniela I Uribe-LópezDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
María Teresa HerreraDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0001-7941-5468
Luis Horacio Gutiérrez-GonzálezLaboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0003-0708-0448
Yolanda GonzálezDepartment of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-7066-6188

Funding

Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI) CF-2023-I-982.
6 · The paper itself

Abstract

This study explores the role of human visceral white adipocytes (hv-WAD) in latent tuberculosis infection (LTBI). While granulomas and macrophages are traditionally viewed as central to TB latency, emerging evidence highlights adipocytes as significant non-canonical host cells that may facilitate bacterial persistence by providing a protective niche. Unlike the immune-driven environment within granulomas, adipocytes can shield

Indexed as

Adipocytes, WhiteCytokinesLatent TuberculosisMycobacterium tuberculosisAdultBacterial ProteinsFemaleHumansIntra-Abdominal FatMaleMiddle AgedVirulence FactorsBacterial ProteinsCytokinesVirulence Factorsdormancy-associate geneshuman visceral white adipocyteslatent tuberculosis infectionMycobacterium tuberculosis

Identifiers

PMID41373747
PMCPMC12692136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.